AM, B., AM, O., A, I., B, B., BA, B., HFA, V., . . . ME, v. L. (2024). The Added Value of Blood Glucose Monitoring in High-Risk Individuals Undergoing Pancreatic Cancer Surveillance. Pancreas, 53(7), e566. https://doi.org/10.1097/MPA.0000000000002335
Chicago Style (17th ed.) CitationAM, Bogdanski, et al. "The Added Value of Blood Glucose Monitoring in High-Risk Individuals Undergoing Pancreatic Cancer Surveillance." Pancreas 53, no. 7 (2024): e566. https://doi.org/10.1097/MPA.0000000000002335.
MLA (9th ed.) CitationAM, Bogdanski, et al. "The Added Value of Blood Glucose Monitoring in High-Risk Individuals Undergoing Pancreatic Cancer Surveillance." Pancreas, vol. 53, no. 7, 2024, p. e566, https://doi.org/10.1097/MPA.0000000000002335.
Warning: These citations may not always be 100% accurate.